DeutschNewstral
Article
Forbes on 2023-07-20 12:00
Philip Morris To Acquire Israeli Cannabis Inhaler Company Syqe Medical For Up To $650 Million
Related news
Israeli medical cannabis inhaler gets Canada’s marketing nodtimesofisrael.com- LISTEN: How a young weed grower went on to found a cannabis inhaler startuptimesofisrael.com
- Philip Morris investment in Syqe was 2nd-largest 2016 cannabis deal – reporttimesofisrael.com
- JIsraeli company to market medical cannabis inhalerjewishpresspinellas.com
- FTobacco group Philip Morris wins control of inhaler company Vecturaft.com
- FPhilip Morris launches counterbid for inhaler specialist Vecturaft.com
Philip Morris results mixed, disappointingThe Salt Lake Tribune- MVaping, cannabis and, yes, life insurance — the Philip Morris and Altria merger talks are about more than cigarettesmarketwatch.com
- Breakthrough cannabis inhaler weds medical tech, 3D printingtimesofisrael.com
Israelis develop first ‘metered-dose’ medical cannabis inhalerThe Jerusalem Post (JPost.com)
Philip Morris Int’l results mixed, outlook disappointsseattletimes.com- FPhilip Morris keeps powder dry on cannabisft.com
Philip Morris could stop selling cigarettesNew York Post- Philip Morris, Altria call off merger talksNew York Post
- Is Philip Morris Stock Fairly Valued?Forbes
Cigarette giant Philip Morris slashes Australian workforceSydney Morning Herald- Philip Morris 2Q results beat expectationsThe Salt Lake Tribune
Analysis Israel's Huge Gift to Philip MorrisHaaretz
Philip Morris tops Street 1Q forecastsdailyherald.com